RCBTB1
RCC1 and BTB domain-containing protein 1
Also known as: CLLD7, CLLL7, FLJ10716, RCBT1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NDN9
- Gene
- RCBTB1
- Ensembl
- ENSG00000136144
- Chromosome
- 13
- Canonical length
- 531 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a protein with an N-terminal RCC1 domain and a C-terminal BTB (broad complex, tramtrack and bric-a-brac) domain. In rat, over-expression of this gene in vascular smooth muscle cells induced cellular hypertrophy. In rat, the C-terminus of RCBTB1 interacts with the angiotensin II receptor-1A. In humans, this gene maps to a region of chromosome 13q that is frequently deleted in B-cell chronic lymphocytic leukemia and other lymphoid malignancies. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
531 residues, UniProt reviewed canonical sequence.
>Q8NDN9|RCBTB1
1 MVDVGKWPIF TLLSPQEIAS IRKACVFGTS ASEALYVTDN DEVFVFGLNY SNCLGTGDNQ
61 STLVPKKLEG LCGKKIKSLS YGSGPHVLLS TEDGVVYAWG HNGYSQLGNG TTNQGIAPVQ
121 VCTNLLIKQV VEVACGSHHS MALAADGEVF AWGYNNCGQV GSGSTANQPT PRKVTNCLHI
181 KRVVGIACGQ TSSMAVLDNG EVYGWGYNGN GQLGLGNNGN QLTPVRVAAL HSVCVNQIVC
241 GYAHTLALTD EGLLYAWGAN TYGQLGTGNK NNLLSPAHIM VEKERVVEIA ACHSAHTSAA
301 KTQGGHVYMW GQCRGQSVIL PHLTHFSCTD DVFACFATPA VSWRLLSVEH EDFLTVAESL
361 KKEFDSPETA DLKFRIDGKY IHVHKAVLKI RCEHFRSMFQ SYWNEDMKEV IEIDQFSYPV
421 YRAFLQYLYT DTVDLPPEDA IGLLDLATSY CENRLKKLCQ HIIKRGITVE NAFSLFSAAV
481 RYDAEDLEEF CFKFCINHLT EVTQTAAFWQ MDGPLLKEFI AKASKCGAFK NLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RCBTB1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 46 nTPM
Expression across tissuesHPA
Tissue
- retina: 46 nTPM
- parathyroid gland: 46 nTPM
- thyroid gland: 41 nTPM
- spinal cord: 29 nTPM
- midbrain: 28 nTPM
- hippocampal formation: 22 nTPM
Single-cell type
- cone photoreceptor cells: 147 nCPM
- rod photoreceptor cells: 125 nCPM
- oligodendrocyte progenitor cells: 107 nCPM
- oligodendrocytes: 94 nCPM
- microglia: 68 nCPM
- megakaryocyte-erythroid progenitors: 61 nCPM
Immune cell
- basophil: 17 nTPM
- T-reg: 9.2 nTPM
- non-classical monocyte: 8.9 nTPM
- myeloid DC: 7.6 nTPM
- intermediate monocyte: 7.4 nTPM
- eosinophil: 6.5 nTPM
Brain region
- hypothalamus: 44 nTPM
- white matter: 44 nTPM
- basal ganglia: 43 nTPM
- thalamus: 39 nTPM
- midbrain: 39 nTPM
- medulla oblongata: 39 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RCBTB1.
Disease | AllUniProt
Conditions RCBTB1 is implicated in, by any mechanism.
- Retinal dystrophy with or without extraocular anomalies (RDEOA) MIM:617175
Disease | GeneticClinVar
34 pathogenic / likely-pathogenic of 448 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- RCBTB1-related retinopathy
- Retinitis pigmentosa
- Coats disease
- Retinal dystrophy
- Familial exudative vitreoretinopathy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.79
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.03
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- BTB/POZ domain
- Regulator of chromosome condensation, RCC1
- Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II
- SKP1/BTB/POZ domain superfamily
- Diverse Signaling and Regulatory Domain-Containing Protein
- RCC1-like domain
- BTB/POZ domain
- RCC1-like domain
- RCC1 and BTB domain-containing protein 1, BTB/POZ domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RCBTB1 as an antibody target. Whether an autoantibody or antibody against RCBTB1 could matter depends on whether native RCBTB1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RCBTB1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RCBTB1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...